Zobrazeno 1 - 5
of 5
pro vyhledávání: '"van Uem JM"'
Autor:
Sánchez-Ferro Á; HM CINAC, Hospital Universitario HM Puerta del Sur, Móstoles, Madrid, Spain. asferro@mit.edu.; Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. asferro@mit.edu., Elshehabi M; Center for Neurology and Hertie Institute for Clinical Brain Research (HIH), Department of Neurodegeneration, University of Tübingen, Tübingen, Germany.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany., Godinho C; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.; Center of Interdisciplinary Research Egas Moniz (CiiEM), Instituto Superior de Ciências da Saúde Egas Moniz, Monte de Caparica, Portugal.; CNS-Campus Neurológico Sénior, Torres Vedras, Portugal., Salkovic D; Center for Neurology and Hertie Institute for Clinical Brain Research (HIH), Department of Neurodegeneration, University of Tübingen, Tübingen, Germany.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany., Hobert MA; Center for Neurology and Hertie Institute for Clinical Brain Research (HIH), Department of Neurodegeneration, University of Tübingen, Tübingen, Germany.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany., Domingos J; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.; CNS-Campus Neurológico Sénior, Torres Vedras, Portugal., van Uem JM; Center for Neurology and Hertie Institute for Clinical Brain Research (HIH), Department of Neurodegeneration, University of Tübingen, Tübingen, Germany.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany., Ferreira JJ; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.; CNS-Campus Neurológico Sénior, Torres Vedras, Portugal.; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Portugal., Maetzler W; Center for Neurology and Hertie Institute for Clinical Brain Research (HIH), Department of Neurodegeneration, University of Tübingen, Tübingen, Germany.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany.
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2016 Sep; Vol. 31 (9), pp. 1283-92. Date of Electronic Publication: 2016 Jul 19.
Autor:
van Uem JM; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany., Maier KS; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany., Hucker S; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany., Scheck O; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany., Hobert MA; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany., Santos AT; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal., Fagerbakke Ø; Norwegian Centre for Telemedicine, Tromsø, Norway., Larsen F; Norwegian Centre for Telemedicine, Tromsø, Norway., Ferreira JJ; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal., Maetzler W; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany. walter.maetzler@uni-tuebingen.de.; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany. walter.maetzler@uni-tuebingen.de.
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2016 Sep; Vol. 31 (9), pp. 1337-8. Date of Electronic Publication: 2016 May 31.
Autor:
Van Uem JM; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany.; DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Germany., Walgaard S; McRoberts, The Hague, The Netherlands., Ainsworth E; McRoberts, The Hague, The Netherlands., Hasmann SE; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany.; DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Germany., Heger T; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany.; DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Germany., Nussbaum S; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany.; DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Germany., Hobert MA; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany.; DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Germany., Micó-Amigo EM; McRoberts, The Hague, The Netherlands.; MOVE Research Institute Amsterdam, Department of Human Movement Sciences, VU University Amsterdam, Amsterdam, The Netherlands., Van Lummel RC; McRoberts, The Hague, The Netherlands., Berg D; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany.; DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Germany., Maetzler W; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany.; DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Germany.
Publikováno v:
PloS one [PLoS One] 2016 Apr 07; Vol. 11 (4), pp. e0151997. Date of Electronic Publication: 2016 Apr 07 (Print Publication: 2016).
Autor:
van Uem JM; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany.; DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Germany., Isaacs T; The Cure Parkinson's Trust, London, UK., Lewin A; The Cure Parkinson's Trust, London, UK., Bresolin E; The Cure Parkinson's Trust, London, UK., Salkovic D; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany.; DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Germany., Espay AJ; Gardner Center for Parkinson's disease and Movement Disorders, University of Cincinnati, Cincinnati, Ohio, USA., Matthews H; The Cure Parkinson's Trust, London, UK., Maetzler W; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany.; DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Germany.
Publikováno v:
Journal of Parkinson's disease [J Parkinsons Dis] 2016 Mar 10; Vol. 6 (2), pp. 279-87.
Autor:
van Uem JM; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Center of Neurology, University of Tuebingen, Tuebingen, Germany; German Center for Neurodegenerative Diseases, DZNE, Tuebingen, Germany. Electronic address: janet.uem@uni-tuebingen.de., Marinus J; Department of Neurology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. Electronic address: J.Marinus@lumc.nl., Canning C; Clinical and Rehabilitation Sciences Research Group, Faculty of Health Sciences, The University of Sydney, PO Box 170, Lidcombe, Sydney 1825, NSW, Australia. Electronic address: Colleen.canning@sydney.edu.au., van Lummel R; McRoberts, Raamweg 43, 2596 HN The Hague, The Netherlands. Electronic address: R.vanLummel@mcroberts.nl., Dodel R; Department of Neurology, Philipps-University, Baldingerstrasse, D-35043 Marburg, Germany. Electronic address: Dodel@med.uni-marburg.de., Liepelt-Scarfone I; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Center of Neurology, University of Tuebingen, Tuebingen, Germany; German Center for Neurodegenerative Diseases, DZNE, Tuebingen, Germany. Electronic address: inga.liepelt@uni-tuebingen.de., Berg D; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Center of Neurology, University of Tuebingen, Tuebingen, Germany; German Center for Neurodegenerative Diseases, DZNE, Tuebingen, Germany. Electronic address: daniela.berg@uni-tuebingen.de., Morris ME; Physiotherapy, School of Allied Health, College of Science, Health and Engineering, La Trobe, Melbourne 3086, VIC, Australia. Electronic address: M.morris@latrobe.edu.au., Maetzler W; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Center of Neurology, University of Tuebingen, Tuebingen, Germany; German Center for Neurodegenerative Diseases, DZNE, Tuebingen, Germany. Electronic address: walter.maetzler@uni-tuebingen.de.
Publikováno v:
Neuroscience and biobehavioral reviews [Neurosci Biobehav Rev] 2016 Feb; Vol. 61, pp. 26-34. Date of Electronic Publication: 2015 Dec 02.